Австралия - английский - APVMA (Australian Pesticides and Veterinary Medicines Authority)

australis crop protection pty ltd - ethephon - soluble concentrate - ethephon organophosphorus active 900.0 g/l - growth regulator

Австралия - английский - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - insulin glargine, quantity: 3.6378 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; metacresol; water for injections; zinc chloride; sodium hydroxide; glycerol - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for control of hyperglycaemia.

Австралия - английский - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sumitomo chemical australia pty. limited - clothianidin - water dispersible granule - clothianidin ungrouped active 500.0 g/kg - insecticide - apple | grape - table | grape - wine | nectarine | peach | pear | barlinka | cardinal | delicious | flame seedless | golden deli - codling moth | green peach aphid | longtailed mealy bug | oriental fruit moth | tuber mealybug | woolly aphid

Австралия - английский - APVMA (Australian Pesticides and Veterinary Medicines Authority)

eurochem pty. ltd. - cyanamide - aqueous concentrate - cyanamide cyanide active 520.0 g/l - growth regulator - grape - table | grape - wine | kiwi fruit | barlinka | cardinal | chinese gooseberry | flame seedless | grapevine | muscat of ha - regulation of bud dormancy

Австралия - английский - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; hypromellose - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; maltodextrin; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: stearic acid; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: hypromellose; stearic acid; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 80 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - indicated for the treatment of diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - gliclazide, quantity: 80 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; maize starch; magnesium stearate; lactose monohydrate; purified talc - indications as at 3 november 1999: diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone.